New Zealand Authorizes Controlled MDMA Access for PTSD

New Zealand has greenlit a restricted pathway for psychiatrists to prescribe pharmaceutical-grade MDMA to adult PTSD patients.

By The Herb House Desk·September 8, 2026
New Zealand Authorizes Controlled MDMA Access for PTSD

New Zealand has authorized two psychiatrists to prescribe pharmaceutical-grade MDMA for certain adults suffering from post-traumatic stress disorder. This initiative establishes a closely regulated treatment avenue, even as the substance maintains its unapproved status generally.

This development provides a structured, albeit limited, access point for MDMA therapy within the country's medical framework.

Source: High Times.

Reporting informed by public dispatches from High Times.